Podchaser Logo
Home
TX Biobytes from Texas Biomed Episode 050 — New Coronavirus: Q&A

TX Biobytes from Texas Biomed Episode 050 — New Coronavirus: Q&A

Released Wednesday, 26th February 2020
Good episode? Give it some love!
TX Biobytes from Texas Biomed Episode 050 — New Coronavirus: Q&A

TX Biobytes from Texas Biomed Episode 050 — New Coronavirus: Q&A

TX Biobytes from Texas Biomed Episode 050 — New Coronavirus: Q&A

TX Biobytes from Texas Biomed Episode 050 — New Coronavirus: Q&A

Wednesday, 26th February 2020
Good episode? Give it some love!
Rate Episode

New Coronavirus - Credit: NIH NIAID

As of today, February 26, 2020, the new coronavirus has infected more than 80,000 people worldwide, causing more than 2,200 deaths, and continues to be spreading. The CDC has warned that the virus is likely to spread in the United States. Scientists worldwide are frantically searching for therapies and vaccines to combat this threat and there appears to be some progress; however, any vaccine or therapeutic candidate will still have to undergo rigorous testing, including testing in animal models, which Texas Biomed is developing.

Texas BioBytes sat down with three leading researchers to discuss the virus, scientific progress and what individuals can do to protect themselves. We spoke on February 17 with Dr. Larry Schlesinger, Professor, President and CEO of Texas Biomed; Dr. Jean Patterson, Professor, and this week's podcast also introduces Texas Biomed's newest faculty member and leading virologist on vaccine development Dr. Luis Martinez Sobrido, Professor. All facts and figures are from the time of the interview. Please join us for this roundtable discussion of one of the world's most current threats.

 

Show More
Rate

Join Podchaser to...

  • Rate podcasts and episodes
  • Follow podcasts and creators
  • Create podcast and episode lists
  • & much more

Episode Tags

Do you host or manage this podcast?
Claim and edit this page to your liking.
,

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features